Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCT1 Variants and Metformin Response in Healthy Subjects
NCT00187681Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Jul 2003
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Area Under the Curve of Blood Concentration-time of Metformin and Glucose Lowering Response to Metformin. Started Jul 2003; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00187681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00187681.